Minya University Faculty of Dentistry
Minya, Egypt
Location status: Recruiting
NCT Number: NCT07138287
Concerned Growth factor versus Miniral Trioide aggregate in management of Mature permanent Molar of children with irreversible pulpitis
Interested in participating?
Request Info9 year–16 year
All sexes
Interventional
Not applicable
Minya, Egypt
Location status: Recruiting
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Permanent Molar with closed Apex and diagnosed with irreversible pulpitis
-
Exclusion criteria
Concerned Growth factor in management of Mature permanent Molar of children with irreversible pulpitis
Other names: Pulpotomy
Time frame: 12 months
Pain assessment using visual analogue scale pre operative, 6 hours post operative, 12hours post operative, 1 day post operative, 2 days post operative, 4 days, 1week, 2 weeks, 1month, 3 months, 6months and 1 year Sensibility test using thermal both hot and cold will be done pre operative and post operative Electrical pulp testing pre operative and post operative follow ups Percussion test to define any periapical or Periodontal issues
Time frame: 12 months
Standerdized periapical x rax will be performed before treatment, 3 months, 6minths, 9 months and one year after pulpotomy in the treated teeth to evaluated radiographic sucess
Contact information is provided by the study sponsor or research team.
Minia University
Other
Concerned Growth Factor Versus Miniral Trioide Aggregate in Management of Mature Permanent Molar of Children With Irreversible Pulpitis. An 18-month Randomized Control Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.